Cross Country Healthcare (NASDAQ:CCRN) Issues Q1 2026 Earnings Guidance

Cross Country Healthcare (NASDAQ:CCRN) issued an update on its first quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of -0.060–0.040 for the period, compared to the consensus earnings per share estimate of 0.030. The company issued revenue guidance of $235.0 million-$240.0 million, compared to the consensus revenue estimate of $253.5 million.

Cross Country Healthcare Stock Down 6.1%

Shares of CCRN stock opened at $8.57 on Thursday. The firm has a 50-day moving average price of $8.62 and a 200 day moving average price of $10.77. Cross Country Healthcare has a 12-month low of $7.43 and a 12-month high of $16.84. The company has a market capitalization of $280.75 million, a P/E ratio of -17.49, a P/E/G ratio of 6.60 and a beta of 0.42.

Cross Country Healthcare (NASDAQ:CCRN) last posted its quarterly earnings results on Wednesday, March 4th. The business services provider reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.09). Cross Country Healthcare had a positive return on equity of 0.95% and a negative net margin of 1.39%.The company had revenue of $236.76 million during the quarter, compared to the consensus estimate of $254.30 million. Cross Country Healthcare has set its Q1 2026 guidance at -0.060–0.040 EPS. As a group, research analysts expect that Cross Country Healthcare will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Truist Financial set a $10.00 price objective on shares of Cross Country Healthcare in a research report on Tuesday, December 16th. UBS Group cut their target price on Cross Country Healthcare from $16.50 to $9.00 and set a “neutral” rating on the stock in a report on Tuesday, December 9th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cross Country Healthcare in a research report on Monday, December 29th. Citizens Jmp set a $11.00 price objective on Cross Country Healthcare in a research note on Thursday, December 4th. Finally, Citigroup restated a “market outperform” rating on shares of Cross Country Healthcare in a research report on Friday, December 19th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Cross Country Healthcare has an average rating of “Hold” and an average target price of $11.75.

Cross Country Healthcare News Roundup

Here are the key news stories impacting Cross Country Healthcare this week:

• Positive Sentiment: Benchmark Co. upgraded CCRN from “Hold” to “Buy” and set a $14 price target (~53% above the current level), which could attract buyers and provide near-term upside if the story or fundamentals stabilize. Finviz
• Neutral Sentiment: William Blair reiterated a Hold, citing market-share losses and a soft outlook but noting stabilizing demand and a solid balance sheet — this keeps professional sentiment mixed rather than decisively bullish or bearish. TipRanks / William Blair note
• Neutral Sentiment: Earnings call transcripts and coverage are available for investors who want management commentary and color on demand trends and cost actions; these provide detail but do not change the headline miss. Seeking Alpha transcript
• Negative Sentiment: Q4 results missed expectations: EPS of ($0.06) vs. consensus $0.03 and revenue $236.8M vs. estimates ~\$254M — a clear beat/miss that pressured the stock. MarketBeat earnings summary
• Negative Sentiment: Management set weak Q1 2026 guidance (EPS -$0.060 to -$0.040 vs. consensus +$0.03; revenue \$235–240M vs. consensus ~\$253.5M), signaling near-term softness in demand and extending investor uncertainty. Zacks coverage
• Negative Sentiment: Market reaction was negative: media reported a sharp intraday drop (one headline cited ~14% slide) as investors digested the miss and weak guidance. Investing.com report
• Negative Sentiment: Third‑party coverage (QuiverQuant) highlights steeper year‑over‑year declines in revenue and profitability and wider operating losses, though it also notes a stronger cash balance — mixed fundamentals but near‑term negative pressure. QuiverQuant summary
• Neutral Sentiment: Short-interest and days-to-cover figures in recent reports appear inconsistent or erroneous (showing zeros); treat those data points cautiously until corrected. (No reliable link available in the feed.)

Institutional Trading of Cross Country Healthcare

Large investors have recently made changes to their positions in the business. Quinn Opportunity Partners LLC bought a new stake in shares of Cross Country Healthcare in the 4th quarter valued at about $8,470,000. Boston Partners purchased a new stake in Cross Country Healthcare during the 4th quarter valued at about $6,414,000. Goldman Sachs Group Inc. lifted its position in Cross Country Healthcare by 56.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider’s stock worth $16,307,000 after buying an additional 397,216 shares in the last quarter. Barclays PLC grew its holdings in shares of Cross Country Healthcare by 804.8% in the fourth quarter. Barclays PLC now owns 398,851 shares of the business services provider’s stock valued at $3,231,000 after purchasing an additional 354,771 shares during the period. Finally, Walleye Capital LLC acquired a new position in Cross Country Healthcare during the 4th quarter worth about $2,055,000. 96.03% of the stock is currently owned by institutional investors.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.

The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.